Galmed Pharmaceuticals Ltd.
GLMD
|
$0.333
-11.46%
-12.94%
97K
|
Health Technology
(0.0% 1d) (21.0% 1m) (-99.5% 1y) (0.0% 2d) (0.0% 3d) (-6.0% 7d) (-44.29% volume)
Earnings Calendar: 2022-11-07
Market Cap: $ 1,680,093
http://www.galmedpharma.com
Sec Filling | Patents | 21 employees
(IL) Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
diabetes diabetic israel hepatitis nash treatment
add to watch list Paper trade email alert is off
Press-releases
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
Published: 2024-04-04 (Crawled : 21:00) - prnewswire.com
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: -2.42%
H: 5.59%
C: 5.59%
report year pharmaceuticals for
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
Published: 2024-03-15 (Crawled : 13:00) - prnewswire.com
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: 17.48%
H: 0.0%
C: -25.59%
mgl-3196 patent liver treatment fibrosis grant aramchol nash
Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.6%
H: 1.1%
C: -1.18%
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.27%
H: 0.12%
C: 0.12%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: 0.0%
H: 0.5%
C: 0.17%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.86%
H: 0.34%
C: -0.19%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -1.01%
H: 0.39%
C: 0.19%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.51%
H: 0.68%
C: 0.32%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: 0.03%
H: 2.44%
C: -1.03%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -0.37%
america market
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
Published: 2023-11-20 (Crawled : 23:00) - biospace.com/
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: -0.52%
H: 7.23%
C: 7.23%
study
Global NASH Market to Soar to $2.71 Billion by 2023, Driven by Rising Prevalence of Silent Liver Disease
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
| Email alert
Add to watchlist
GALT | $3.4 -13.04% -15.0% 350K
|
Health Technology
| Email alert
Add to watchlist
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
| Email alert
Add to watchlist
GNFT | $3.5201 4.03% 8.4K
|
Health Technology
| Email alert
Add to watchlist
ICPT | $19.0 -0.05% 4M
|
Health Technology
| Email alert
Add to watchlist
IVA | $3.2 -2.44% -2.5% 15K
|
Health Technology
| Email alert
Add to watchlist
MDGL M | $233.15 0.77% 0.76% 340K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $135.94 -4.19% 770
|
Health Technology
| Email alert
Add to watchlist
IVEVF | $3.73 0% 1K
|
n/a
| Email alert
Add to watchlist
liver disease global nash market
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
Published: 2023-09-26 (Crawled : 14:30) - biospace.com/
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: -2.0%
H: 5.0%
C: -0.66%
patent treatment fibrosis aramchol
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
Published: 2023-09-22 (Crawled : 20:00) - prnewswire.com
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
| Email alert
Add to watchlist
nasdaq pharmaceuticals
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
Published: 2023-07-14 (Crawled : 15:00) - biospace.com/
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: -31.6%
offering pharmaceuticals
Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC
Published: 2023-07-10 (Crawled : 14:00) - biospace.com/
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: 9.43%
H: 0.0%
C: -13.1%
trial
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments
Published: 2023-06-01 (Crawled : 18:00) - biospace.com/
GLMD | $0.333 -11.46% -12.94% 97K
|
Health Technology
|
| O: 0.0%
H: 6.94%
C: 0.43%
pharmaceuticals financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Last 48 Hours Insiders Buying
KFS P 481 | $8.6 1.06% 0.0% 15K
|
Finance
|
20:30
AINC | $4.83 -1.43% 1.45% 98K
|
Finance
|
20:30
RVP P 3587 | $1.065 -1.39% 0.47% 49K
|
Health Technology
|
17:00
TPL P 12 | $586.93 0.52% 0.0% 50K
|
Miscellaneous
|
16:01
HNRA | $2.76 16.95% -1.81% 400K
|
n/a
|
15:02
TGEN | $0.67 39.71% 16K
|
Utilities
|
14:30
RMCF | $3.6492 -7.2% 9.2K
|
Consumer Non-Durables
|
20:10